百济神州达成9.5亿美元交易,玩转资本,迈向“全球价值变现”

CPHI制药在线
Aug 26

关注并星标CPHI制药在线*展会预登记火热进行中, 扫描二维码免费领票!近日,百济神州与Royalty Pharma达成一项高达9.5亿美元的特许权使用费交易,引发行业广泛关注。这不仅是一次资本与研发的高效对接,更是中国生物科技企业从“自主研发”迈向“全球价值变现”的重要里程碑。9.5 亿美元此次交易,Royalty Pharma 将在交割时支付 8.85 亿美元首付款,用于购买 DLL3/CD3...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10